Page last updated: 2024-11-05

trihexyphenidyl and Craniocerebral Trauma

trihexyphenidyl has been researched along with Craniocerebral Trauma in 3 studies

Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.

Craniocerebral Trauma: Traumatic injuries involving the cranium and intracranial structures (i.e., BRAIN; CRANIAL NERVES; MENINGES; and other structures). Injuries may be classified by whether or not the skull is penetrated (i.e., penetrating vs. nonpenetrating) or whether there is an associated hemorrhage.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
LECHNER, H1
TURNER, JW1
Kaijima, M1
Fukuda, H1
Tomabechi, M1
Hodozuka, A1

Other Studies

3 other studies available for trihexyphenidyl and Craniocerebral Trauma

ArticleYear
[Anticholinergic therapy of craniocerebral trauma].
    Wiener klinische Wochenschrift, 1963, Jul-19, Volume: 75

    Topics: Brain Injuries; Cholinergic Antagonists; Craniocerebral Trauma; Humans; Parasympatholytics; Scopolam

1963
PARKINSONISM: AETIOLOGY AND TREATMENT.
    London Clinic medical journal, 1964, Volume: 5

    Topics: Carbon Monoxide Poisoning; Craniocerebral Trauma; Drug Therapy; Encephalitis; Intracranial Arteriosc

1964
[Effect of trihexyphenidyl-HCL on posttraumatic prolonged disturbance of consciousness: report of two cases].
    No shinkei geka. Neurological surgery, 1989, Volume: 17, Issue:5

    Topics: Aged; Akinetic Mutism; Craniocerebral Trauma; Humans; Magnetic Resonance Imaging; Male; Middle Aged;

1989